4//SEC Filing
van Hylckama Vlieg Johan 4
Accession 0001209191-21-054435
CIK 0001751299other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:23 PM ET
Size
5.3 KB
Accession
0001209191-21-054435
Insider Transaction Report
Form 4
van Hylckama Vlieg Johan
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-09-01+40,000→ 40,000 totalExercise: $6.29Exp: 2031-08-31→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on September 1, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.
Documents
Issuer
Kaleido Biosciences, Inc.
CIK 0001751299
Entity typeother
Related Parties
1- filerCIK 0001861087
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 4:23 PM ET
- Size
- 5.3 KB